Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06068712 · ClinicalTrials.gov registry record · NA

Proactive and Reactive Attention to Negative Templates

A NA study of Healthy, sponsored by Lehigh University.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT06068712: Completed NA study of Healthy, sponsored by Lehigh University.

NCT06068712 is a NA study of Healthy that has completed, run by Lehigh University. The registered enrollment target is 19 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06068712, a NA study of Healthy, has completed, sponsored by Lehigh University.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

EEG Measures during Visual Search Task. In this line of research, the researchers having participants receive a positive (target) template cue, negative (distractor) template cue, or neutral (non-informative) template cue. Note: This is a re-analysis of previously collected data.

Primary Outcome

Speed to respond correctly to the target- after participant finds the target shape on a computer screen, they press a button to indicate what shape they see

Conditions Studied

Interventions

  • BEHAVIORAL Attentional Cue Type

Study Locations (1)

Pennsylvania

  • Lehigh University - Bethlehem

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2014-10-11
Est. Completion 2015-04-02
Phase NA
Lehigh University

12 total trials

What the finished NCT06068712 record still lists

NCT06068712 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Attentional Cue Type is the first listed.

NCT06068712 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06068712 about?

NCT06068712 is a clinical study titled "Proactive and Reactive Attention to Negative Templates". EEG Measures during Visual Search Task. In this line of research, the researchers having participants receive a positive (target) template cue, negative (distractor) template cue, or neutral (non-informative) template cue. Note: This is a re-analysis of previously collected data.

What is the current status of trial NCT06068712?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2014-10-11. Estimated completion is 2015-04-02.

What conditions does trial NCT06068712 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT06068712?

The interventions under investigation include: Attentional Cue Type (BEHAVIORAL).

Who is sponsoring clinical trial NCT06068712?

This trial is sponsored by Lehigh University, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06068712 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06068712's enrollment target sits among peer trials

19 898th of 1090 higher than 188 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03207464 · 19 participants · Phase 1

    Molecular Imaging of NET Using [C-11]MRB-PET in MS

  • NCT04318717 · 19 participants · Phase 2

    Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma

  • NCT05103904 · 19 participants · Phase 2

    Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant

  • NCT05607407 · 19 participants · Phase 2

    Methimazole in Patients With Progressive Glioblastoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06068712, the US trial registry maintained by the National Library of Medicine. NCT06068712 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.